Rutgers Cancer Institute of New Jersey,150 Bergen St.
Newark, New Jersey, United States
Cancer treatment center in Newark, New Jersey
205 S Orange Ave, Newark, NJ 07103
About Rutgers Cancer Institute of New Jersey,150 Bergen St.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Rutgers Cancer Institute of New Jersey,150 Bergen St.
During the past decade, Rutgers Cancer Institute of New Jersey,150 Bergen St. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Rutgers Cancer Institute of New Jersey,150 Bergen St."
#1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Rutgers Cancer Institute of New Jersey,150 Bergen St.
According to Clinical.Site data, the most researched conditions in "Rutgers Cancer Institute of New Jersey,150 Bergen St." are
"Triple Negative Breast Cancer" (2 trials), "PD-L1 Negative" (1 trials) and "PD-L1 Positive" (1 trials). Many other conditions were trialed in "Rutgers Cancer Institute of New Jersey,150 Bergen St." in a lesser frequency.
Clinical Trials Intervention Types at Rutgers Cancer Institute of New Jersey,150 Bergen St.
Most popular intervention types in "Rutgers Cancer Institute of New Jersey,150 Bergen St." are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials), "Sacituzumab Govitecan-hziy" (2 trials) and "nab-Paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Rutgers Cancer Institute of New Jersey,150 Bergen St.
The vast majority of trials in "Rutgers Cancer Institute of New Jersey,150 Bergen St." are
2 trials for "All" genders.
Clinical Trials Status at Rutgers Cancer Institute of New Jersey,150 Bergen St.
Currently, there are NaN active trials in "Rutgers Cancer Institute of New Jersey,150 Bergen St.".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Rutgers Cancer Institute of New Jersey,150 Bergen St.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Rutgers Cancer Institute of New Jersey,150 Bergen St., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".